Patents by Inventor Jennifer Ozug

Jennifer Ozug has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • POLYSACCHARIDE COMPOSITIONS AND RELATED METHODS
    Publication number: 20160120896
    Abstract: The disclosure provides LMWH preparations and methods of analyzing LMWH preparations having at least one chain having a glycol split uronic acid residue (UG) in the preparation for structural signatures, and methods of producing such preparations based upon the analysis.
    Type: Application
    Filed: May 27, 2014
    Publication date: May 5, 2016
    Inventors: Jing Wang, Elaine Y. Sun, Kristaq Vezuli, Daniela Beccati, Birgit Schultes, Jennifer Ozug, Miroslaw Lech, Fei Yu
  • Method of analyzing a preparation of a low molecular weight heparin
    Patent number: 9139876
    Abstract: Methods for analyzing mixtures of polysaccharides, for example heparin such as unfractionated heparin and enoxaparin are described. In some instances, the mixtures are analyzed using high performance liquid chromatography (HPLC), e.g., reverse phase HPLC.
    Type: Grant
    Filed: May 2, 2008
    Date of Patent: September 22, 2015
    Assignee: MOMENTA PHARMACUETICALS, INC.
    Inventors: Zachary Shriver, Naveen Bhatnagar, Nur Sibel Gunay, Jennifer Ozug, Elaine Y. Sun
  • Evaluating heparin preparations
    Patent number: 9068957
    Abstract: Methods of evaluating heparin preparations, e.g., for suitability for use as a drug or for use in making a drug, by determining the absence, presence or amount of a structural signature, wherein, e.g., the structural signature is indicative of the methods used to make the heparin preparation.
    Type: Grant
    Filed: February 21, 2012
    Date of Patent: June 30, 2015
    Assignee: MOMENTA PHARMACEUTICALS, INC.
    Inventors: Nur Sibel Gunay, Miroslaw Lech, Sucharita Roy, John Schaeck, Jennifer Ozug, Daniela Beccati, Ishan Capila
  • EVALUATING HEPARIN PREPARATIONS
    Publication number: 20140114056
    Abstract: Methods of evaluating heparin preparations, e.g., for suitability for use as a drug or for use in making a drug, by determining the absence, presence or amount of a structural signature, wherein, e.g., the structural signature is indicative of the methods used to make the heparin preparation.
    Type: Application
    Filed: February 21, 2012
    Publication date: April 24, 2014
    Applicant: MOMENTA PHARMACEUTICALS, INC.
    Inventors: Nur Sibel Gunay, Miroslaw Lech, Sucharita Roy, John Schaeck, Jennifer Ozug, Daniela Beccati, Ishan Capila
  • Evaluating mixtures of low molecular weight heparins by chain profiles or chain mapping
    Patent number: 8617896
    Abstract: Methods for analyzing mixtures of polysaccharides, for example heparin such as unfractionated heparin and enoxaparin are described. In some instances, the mixtures are analyzed using fast performance liquid chromatography (FPLC) and high liquid performance chromatography (HPLC), e.g., strong anion exchange HPLC.
    Type: Grant
    Filed: June 21, 2012
    Date of Patent: December 31, 2013
    Inventors: Zachary Shriver, Daniela Beccati, Ishan Capila, Nur Sibel Gunay, Jennifer Ozug, Steve Wudyka
  • Evaluating mixtures of low molecular weight heparins by chain profiles or chain mapping
    Patent number: 8252597
    Abstract: Methods for analyzing mixtures of polysaccharides, for example heparin such as unfractionated heparin and enoxaparin are described. In some instances, the mixtures are analyzed using fast performance liquid chromatography (FPLC) and high liquid performance chromatography (HPLC), e.g., strong anion exchange HPLC.
    Type: Grant
    Filed: November 30, 2011
    Date of Patent: August 28, 2012
    Assignee: Momenta Pharmaceuticals, Inc.
    Inventors: Zachary Shriver, Daniela Beccati, Ishan Capila, Nur Sibel Gunay, Jennifer Ozug, Steve Wudyka
  • Evaluating mixtures of low molecular weight heparins by chain profiles or chain mapping
    Patent number: 8076149
    Abstract: Methods for analyzing mixtures of polysaccharides, for example heparin such as unfractionated heparin and enoxaparin are described. In some instances, the mixtures are analyzed using fast performance liquid chromatography (FPLC) and high liquid performance chromatography (HPLC), e.g., strong anion exchange HPLC.
    Type: Grant
    Filed: September 9, 2010
    Date of Patent: December 13, 2011
    Assignee: Momenta Pharmaceuticals, Inc.
    Inventors: Zachary Shriver, Daniela Beccati, Ishan Capila, Nur Sibel Gunay, Jennifer Ozug, Steve Wudyka
  • Evaluating mixtures of low molecular weight heparins by chain profiles or chain mapping
    Patent number: 7816144
    Abstract: Methods for analyzing mixtures of polysaccharides, for example heparin such as unfractionated heparin and enoxaparin are described. In some instances, the mixtures are analyzed using fast performance liquid chromatography (FPLC) and high liquid performance chromatography (HPLC), e.g., strong anion exchange HPLC.
    Type: Grant
    Filed: November 16, 2009
    Date of Patent: October 19, 2010
    Assignee: Momenta Pharmaceuticals, Inc.
    Inventors: Zachary Shriver, Daniela Beccati, Ishan Capila, Nur Sibel Gunay, Jennifer Ozug, Steve Wudyka
  • Evaluating mixtures of low molecular weight heparins by chain profiles or chain mapping
    Patent number: 7790466
    Abstract: Methods for analyzing mixtures of polysaccharides, for example heparin such as unfractionated heparin and enoxaparin are described. In some instances, the mixtures are analyzed using fast performance liquid chromatography (FPLC) and high liquid performance chromatography (HPLC), e.g., strong anion exchange HPLC.
    Type: Grant
    Filed: January 25, 2008
    Date of Patent: September 7, 2010
    Assignee: Momenta Pharmaceuticals, Inc.
    Inventors: Zachary Shriver, Daniela Beccati, Ishan Capila, Nur Sibel Gunay, Jennifer Ozug, Steve Wudyka